ADVANCED MALIGNANCIES THAT HARBOR IDHR132 MUTATIONS

Clinical trials for ADVANCED MALIGNANCIES THAT HARBOR IDHR132 MUTATIONS explained in plain language.

Never miss a new study

Get alerted when new ADVANCED MALIGNANCIES THAT HARBOR IDHR132 MUTATIONS trials appear

Sign up with your email to follow new studies for ADVANCED MALIGNANCIES THAT HARBOR IDHR132 MUTATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New targeted drug enters first human tests for Hard-to-Treat cancers

Disease control Ongoing

This is the first study in people to test the safety and find the right dose of an experimental drug called IDH305. It is for patients with advanced cancers that have a specific genetic change called an IDH1 mutation. The main goal is to see how much of the drug patients can safe…

Matched conditions: ADVANCED MALIGNANCIES THAT HARBOR IDHR132 MUTATIONS

Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

ADVANCED MALIGNANCIES THAT HARBOR IDHR132 MUTATIONS

Get alerted when new ADVANCED MALIGNANCIES THAT HARBOR IDHR132 MUTATIONS trials appear

New targeted drug enters first human tests for Hard-to-Treat cancers